From: Regenerative therapies for femoral head necrosis in the past two decades: a systematic review and network meta-analysis
Comparison
Number of studies included
Conversion to THA at last follow-up time point
I2
CD vs. BMAC
7
28.28%
CD vs. MSCs
1
–
CD vs. PRP
CD vs. ABG
CD vs FVBG
BMAC vs MSCs
ABG vs FVBG
2
14.29%
ABG vs ABG + BMAC
0.00%